Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
Table 1
The clinicopathological characteristics of 68 colorectal neuroendocrine neoplasm patients.
Variance
Rectal NEN () (patients [%])
Colonic NEN () (patients [%])
Gender
NS
Male
26 (60.5)
18 (72.0)
Female
17 (39.5)
7 (28.0)
Age
0.012
≤60
31 (72.1)
10 (40.0)
>60
12 (27.9)
15 (60.0)
Size (mm)
0.000
1–10
30 (69.8)
0 (0)
11–20
6 (13.9)
2 (8.0)
≥21
7 (16.3)
23 (92.0)
T-
0.000
T1
26 (60.5)
0 (0)
T2
9 (20.9)
1 (4.0)
T3
4 (9.3)
12 (48.0)
T4
4 (9.3)
12 (48.0)
0.000
N0
37 (86.0)
10 (40.0)
N1
6 (14.0)
15 (60.0)
0.000
M0
38 (88.4)
12 (48.0)
M1
5 (11.6)
13 (52.0)
Stage
0.000
I
25 (58.1)
0 (0)
II
9 (21.0)
4 (16.0)
III
4 (9.3)
8 (32.0)
IV
5 (11.6)
13 (52.0)
0.001
NET
33 (76.7)
9 (36.0)
NEC
8 (18.6)
8 (32.0)
MANEC
2 (4.7)
8 (32.0)
Ki-67 index (%)
NS
≤2
20 (46.5)
7 (28.0)
3–20
4 (9.3)
2 (8.0)
>20
8 (18.6)
8 (32.0)
Unclear
11 (25.6)
8 (32.0)
-classification, N-classification, M-classification, and stages I, II, III, and IV according to the 7th AJCC TNM staging system. classification according to WHO 2010.
